InflaRx to Present at Upcoming Scientific and Investor Conferences
09 sept. 2022 07h30 HE
|
InflaRx N.V.
JENA, Germany, Sept. 09, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement...
HeartSciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08 sept. 2022 08h30 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
Processa Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 12-14, 2022
07 sept. 2022 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality...
GreenBox POS to Attend the 24th Annual H.C. Wainwright Global Investment Conference
07 sept. 2022 08h00 HE
|
GreenBox POS
SAN DIEGO, CA, Sept. 07, 2022 (GLOBE NEWSWIRE) -- GreenBox POS (NASDAQ: GBOX) (“GreenBox” or “the Company”), a thriving and rapidly growing fintech company today announced management will attend the...
NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022
07 sept. 2022 07h30 HE
|
NEXGEL, INC.
LANGHORNE, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 12-14, 2022
06 sept. 2022 13h15 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative...
ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)
06 sept. 2022 08h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
06 sept. 2022 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that management will participate virtually in the hybrid in-person and virtual H.C. Wainwright 24th...
Nuvectis Pharma to Present in the H.C. Wainwright Global Investment Conference
20 mai 2022 10h21 HE
|
Nuvectis Pharma, Inc.
FORT LEE, NJ, May 20, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the...
Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference
20 mai 2022 09h15 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...